000 01072 a2200265 4500
005 20250515115222.0
264 0 _c20080512
008 200805s 0 0 eng d
022 _a1526-632X
024 7 _a10.1212/01.wnl.0000309214.25038.fd
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGoadsby, Peter J
245 0 0 _aCalcitonin gene-related peptide (CGRP) antagonists and migraine: is this a new era?
_h[electronic resource]
260 _bNeurology
_cApr 2008
300 _a1300-1 p.
_bdigital
500 _aPublication Type: Editorial; Comment
650 0 4 _aCalcitonin Gene-Related Peptide
_xantagonists & inhibitors
650 0 4 _aCalcitonin Gene-Related Peptide Receptor Antagonists
650 0 4 _aHumans
650 0 4 _aMigraine Disorders
_xdrug therapy
650 0 4 _aPharmaceutical Preparations
_xadministration & dosage
650 0 4 _aReceptors, Calcitonin Gene-Related Peptide
_xmetabolism
773 0 _tNeurology
_gvol. 70
_gno. 16
_gp. 1300-1
856 4 0 _uhttps://doi.org/10.1212/01.wnl.0000309214.25038.fd
_zAvailable from publisher's website
999 _c17911619
_d17911619